Sensitive β-galactosidase-targeting fluorescence probe for visualizing small peritoneal metastatic tumours in vivo

Nature Communications

Volumn 6, Issue , 2015, Pages

  Asanuma, Daisuke ^a,b   Sakabe, Masayo ^b   Kamiya, Mako ^a,c   Yamamoto, Kyoko ^a   Hiratake, Jun ^d   Ogawa, Mikako ^e,f   Kosaka, Nobuyuki ^e,g   Choyke, Peter L ^e   Nagano, Tetsuo ^b   Kobayashi, Hisataka ^e   Urano, Yasuteru ^a,b,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e NATIONAL CANCER INSTITUTE   (United States)

^f HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g UNIVERSITY OF FUKUI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; FLUORESCENT DYE;

ENZYME ACTIVITY; FLUORESCENCE; GENE EXPRESSION; MEMBRANE; MOLECULAR ANALYSIS; OPTIMIZATION; TUMOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER DIAGNOSIS; CONTROLLED STUDY; DENSITY FUNCTIONAL THEORY; ENZYME ACTIVITY; FEMALE; FLUORESCENCE; FLUORESCENCE IMAGING; FLUORESCENCE PROBE; HUMAN; HUMAN CELL; IN VIVO STUDY; MOLECULAR PROBE; MOUSE; NONHUMAN; OVARY CANCER; PERITONEUM METASTASIS; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; DISEASE MODEL; ENDOSCOPY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; METABOLISM; METASTASIS; OVARIAN NEOPLASMS; PATHOLOGY; PERITONEAL NEOPLASMS; SECONDARY;

ANIMALS; BETA-GALACTOSIDASE; DISEASE MODELS, ANIMAL; ENDOSCOPY; FEMALE; FLUORESCENT DYES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS;

EID: 84924872548     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms7463     Document Type: Article

References (38)

1. Carmignani, C. P., Sugarbaker, T. A., Bromley, C. M. & Sugarbaker, P. H. Intraperitoneal cancer dissemination: mechanisms of the patterns of spread. Cancer Metastasis Rev. 22, 465-472 (2003).
2. Cotte, E., Passot, G., Gilly, F. N. & Glehen, O. Selection of patients and staging of peritoneal surface malignancies. World J. Gastrointest. Oncol. 2, 31-35 (2010).
3. Lengyel, E. Ovarian cancer development and metastasis. Am. J. Pathol. 177, 1053-1064 (2010).
4. Pecorelli, S., Benedet, J. L., Creasman, W. T., Shephard, J. H. & Pettersson, F. Annual Report on The Results of Treatment in Gynecological Cancer Vol. 23 (International Federation of Gynecology and Obstetrics, 1998).
5. Halkia, E., Spiliotis, J. & Sugarbaker, P. Diagnosis and management of peritoneal metastases from ovarian cancer. Gastroenterol. Res. Pract. 2012, 541842 (2012).
6. rd W. E. et al. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. J. Clin. Oncol. 25, 3621-3627 (2007).
7. rd W. E. et al. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study. J. Clin. Oncol. 26, 83-89 (2008).
8. Löning, M., Diddens, H., Küpker, W., Diedrich, K. & Hüttmann, G. Laparoscopic fluorescence detection of ovarian carcinoma metastases using 5-aminolevulinic acid-induced protoporphyrin IX. Cancer 100, 1650-1656 (2004).
9. Stummer, W. et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 7, 392-401 (2006).
10. Hungerhuber, E. et al. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder. Urology 69, 260-264 (2007).
11. Utsuki, S. et al. Histological examination of false positive tissue resection using 5-aminolevulinic acid-induced fluorescence guidance. Neurol. Med. Chir. 47, 210-213 (2007).
12. Filbeck, T. et al. 5-Aminolevulinic acid-induced fluorescence endoscopy applied at secondary transurethral resection after conventional resection of primary superficial bladder tumors. Urology 53, 77-81 (1999).
13. Koenig, F. et al. Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5-aminolaevulinic acid. BJU Int. 83, 129-135 (1999).
14. van Dam, G. M. et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-a targeting: first in-human results. Nat. Med. 17, 1315-1319 (2011).
15. Urano, Y. et al. Rapid cancer detection by topically spraying a γ-glutamyltranspeptidase-activated fluorescent probe. Sci. Transl. Med. 3, 110-119 (2011).
16. Chatterjee, S. K., Bhattacharya, M. & Barlow, J. J. Glycosyltransferase and glycosidase activities in ovarian cancer patients. Cancer Res. 39, 1943-1951 (1979).
17. Imai, S., Kiyozuka, Y., Maeda, H., Noda, T. & Hosick, H. L. Establishment and characterization of a human ovarian serous cystadenocarcinoma cell line that produces the tumor markers CA-125 and tissue polypeptide antigen. Oncology 47, 177-184 (1990).
18. Hung, M. C. et al. Aberrant expression of the c-erbB-2/neu protooncogene in ovarian cancer. Cancer Lett. 61, 95-103 (1992).
19. Hamilton, T. C. et al. Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res. 43, 5379-5389 (1983).
20. Uehara, S. et al. Establishment and characterization of human ovarian endometrioid carcinoma cell line. Acta Obstet. Gynaecol. Jpn 35, 19-26 (1983).
21. Strachan, R., Wood, J. & Hirschmann, R. Synthesis and properties of 4-methyl-2-oxo-1,2-benzopyran-7-yl β-D-galactoside (galactoside of 4-methylumbelliferone). J. Org. Chem. 27, 1074-1075 (1962).
22. Rotman, B., Zderic, J. A. & Edelstein, M. Fluorogenic substrates for beta-Dgalactosidases and phosphatases derived from fluorescein (3,6-dihydroxyfluoran) and its monomethylether. Proc. Natl Acad. Sci. USA 50, 1-6 (1963).
23. Hofmann, J. & Sernetz, M. Immobilized enzyme kinetics analyzed by flowthrough microfluorimetry: resorufin-β-D-galactopyranoside as a new fluorogenic substrate for b-galactosidase. Anal. Chim. Acta 163, 67-72 (1984).
24. Corey, P. F., Trimmer, R. W. & Biddlecom, W. G. A new chromogenic β-galactosidase substrate: 7-b-D-galactopyranosyloxy-9,9-dimethyl-9H-acridin- 2-one. Angew. Chem. Int. Ed. 30, 1646-1648 (1991).
25. Urano, Y. et al. Evolution of fluorescein as a platform for finely tunable fluorescence probes. J. Am. Chem. Soc. 127, 4888-4894 (2005).
26. Gottesman, M. M., Fojo, T. & Bates, S. E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer 2, 48-58 (2002).
27. Kamiya, M. et al. β-Galactosidase fluorescence probe with improved cellular accumulation based on a spirocyclized rhodol scaffold. J. Am. Chem. Soc. 133, 12960-12963 (2011).
28. Tetko, I. V. & Tanchuk, V. Y. Application of associative neural networks for prediction of lipophilicity in ALOGPS 2.1 program. J. Chem. Inf. Comput. Sci. 42, 1136-1145 (2002).
29. Guo, W. et al. β-D-Glycosylamidines: potent, selective, and easily accessible β-glycosidase inhibitors. Bioorg. Med. Chem. Lett. 11, 467-470 (2001).
30. Hama, Y. et al. A target cell-specific activatable fluorescence probe for in vivo molecular imaging of cancer based on a self-quenched avidin-rhodamine conjugate. Cancer Res. 67, 2791-2799 (2007).
31. Bosmann, H. B. & Hall, T. C. Enzyme activity in invasive tumors of human breast and colon. Proc. Natl Acad. Sci. USA 71, 1833-1837 (1974).
32. Wielgat, P. Activity of lysosomal exoglycosidases in human gliomas. J. Neurooncol. 80, 243-249 (2006).
33. Narita, M. et al. Elevated activity of β-hexosaminidase and sulfhydryl modification in the B-variant of human lung cancer. Cancer Res. 43, 5037-5042 (1983).
34. Gil-Martín, E., Rodríguez-Berrocal, J., Páez, de la Cadena, M. &Fernández-Briera, A. Alterations of glycosidases in human colonic adenocarcinoma. Clin. Biochem. 30, 17-25 (1997).
35. Gil-Martín, E., Gil-Seijo, S., Nieto-Novoa, C. & Fernández-Briera, A. Elevation of acid glycosidase activities in thyroid and gastric tumors. Int. J. Biochem. Cell Biol. 28, 651-657 (1996).
36. Paeker, C. A. & Rees, W. T. Correction of fluorescence spectra and measurement of fluorescence quantum efficiency. Analyst 85, 587-600 (1960).
37. Urano, Y. et al. Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes. Nat. Med. 15, 104-109 (2008).
38. Asanuma, D., Kobayashi, H., Nagano, T. & Urano, Y. Fluorescence imaging of tumors with 'smart' pH-activatable targeted probes. Methods Mol. Biol. 574, 47-62 (2009).